CRISPR-engineered T cells in patients with refractory cancer
2020 · Science · 1,396 citations
https://doi.org/10.1126/science.aba7365
J
Julie K. Jadlowsky
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
3.8K
Citations
19
h-index
24
i10-index
Julie K. Jadlowsky is an academic researcher from California University of Pennsylvania. The author has contributed to research in topics: CAR-T cell therapy research & CRISPR and Genetic Engineering & Immune Cell Function and Interaction. The author has an h-index of 19, co-authored 55 publications.
ORCID: 0009-0005-5115-1321Papers by this author
worksTissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors
2023 · Cell Reports Medicine · 56 citations
https://doi.org/10.1016/j.xcrm.2023.101053
Dominant negative mutant Cyclin T1 proteins inhibit HIV transcription by specifically degrading Tat
2008 · Retrovirology · 21 citations
https://doi.org/10.1186/1742-4690-5-63
Long-term stability of clinical-grade lentiviral vectors for cell therapy
2024 · Molecular Therapy — Methods & Clinical Development · 13 citations
https://doi.org/10.1016/j.omtm.2024.101186
Regulatory Considerations for Genome-Edited T-cell Therapies
2024 · Cancer Immunology Research · 7 citations
https://doi.org/10.1158/2326-6066.cir-24-0482
Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals
2020 · Molecular Therapy · 6 citations
https://doi.org/10.1016/j.ymthe.2020.11.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat